Enhancing Precision Oncology: Exploring PARP Inhibitor Biomarkers For Tailored Cancer Therapy
Precision medicine has revolutionized cancer treatment by targeting therapies based on a patient’s individual tumor biomarkers. Poly (ADP-ribose) polymerase (PARP) inhibitors represent an important class …